Automated dispensing cabinets (ADCs) have been utilized in direct patient care areas since the 1990s, with studies since then evaluating its efficacy in medical error reduction and subsequent cost savings. One previous study using the McLaughlin Dispensing System observed lowered error rate compared to use of doses dispensed from a satellite pharmacy (10.6% vs 15.9%) over a two-week trial period, while another which utilized the Baxter ATC-212 automated dispensing system found daily cart filling time to be significantly reduced, but overall time savings was not significant (<0.5 full-time equivalent), and drug costs were increased due to the acquisition prices for bulk drugs used by the automated dispensing system. In a more recent study, ADCs were observed to reduce overall error rate, but errors of greater severity increased. Though a positive financial impact was observed based on both operation and investment costs, these findings were based on nurses’ time gained, and findings were presented in 2015 Euros. Overall, insufficient evidence is available to determine the extent of dispensing accuracy in patient care areas, necessitating further studies. [1], [2], [3]
A 2014 review examined the clinical and economic impacts of decentralized automated dispensing devices (ADDs), such as Pyxis and Omnicell, in hospital settings. The review explores how use of ADDs in intensive care units (ICUs), general medicine wards, surgical units, or a combination of these locations affect medication management processes, patient safety, and healthcare costs. Within the eight papers included for analysis, ADDs appear to have a benefit in medication storage errors reduction and controlled substance inventory management; however, there was a lack of evidence to support whether ADD use resulted in staff time savings, whether patient harm was reduced as a result of ADD use, or whether costs overall were reduced. Additionally, findings were specific to Canadian hospitals, and applicability to domestic hospitals is uncertain. [4]
A 2015 BD article describes a single institution's implementation of the BD™ Pyxis™ Enterprise solution (ES) in Saudi Arabia, which is a program to convert cart-fill pharmacy distribution of medications to the Pyxis ADC. The ADCs were installed on 31 different units, including operating rooms, labor and delivery units, recovery units, and catheter labs. The formulary was standardized and integrated into the ADC, which assessed the minimum quantity needed for each drug and allowed for timely refills. In the results, the authors found that medication turnaround time was reduced by ~57% while dispensing of the wrong medication was reduced by ~42%, and dispensing to the wrong location was reduced by ~85%. Improvements to clinical workflow were cited as a major benefit that lowered the need for medication preparation, medication checking, and medication delivery to nursing units. No formal cost-saving analysis was performed. Cost savings may be observed by the optimization of inventory use and storage in the APC. [5]
A 2025 systematic review of 129 studies analyzed the different types of automation systems used in hospital pharmacies, assessed the impact of automation, and explored its benefits and challenges/limitations associated with its implementation. Centralized systems designed to prepare and dispense medications from a central pharmacy include distribution and storage robots, unidose preparation robots, intravenous preparation robots (Intravenous Workflow Management Systems, [IVWMS]), and pneumatic tube distribution systems. These systems use a combination of technologies such as barcodes, visual identification (via cameras), radiofrequency identification (RFID), and other advanced methods. On the contrary, ADCs alone are considered decentralized systems. A study in a Brazilian tertiary hospital is referenced, which showed that implementation of automated dispensing robots in the central pharmacy reduced the frequency of errors in both the prescription (from 26% in 2013 to 15% in 2017) and distribution phases (from 36% in 2013 to 33% in 2017). A further study determined that after 7 years of using ADCs at a single institution, the actual return on investment reached +$163,331, confirming ADCs as a profitable investment. Table 10 summarizes reported outcomes of automation on medication administration times and workflow. Automated technologies significantly contribute to reducing medication errors, strengthening traceability, optimizing inventory management, and alleviating the workload of healthcare professionals; however, remaining challenges include cost optimization, integration with existing processes, and need for specialized staff training. The authors note that artificial intelligence may provide new prospects for improving both the accuracy and operational efficiency of medication automation systems. [6]